Xeris Pharmaceuticals | XERS - Lucro Bruto Sobre Vendas





Lucro Bruto Sobre Vendas Alterar Data
Celltrion KRW 39.29B 7.7B 2026-03
Cspc Pharmaceutical CNY 4.01B 329.18M 2025-12
Deva Holding AS TRY 1.32B 235.77M 2023-09
Dianthus Therapeutics USD 463K 179K 2026-03
Divis Laboratories Ltd INR 19.61B 2.49B 2026-06
Eli Lilly USD 16.22B 301.7M 2026-03
Kangmei Pharma CNY 238.34M 31.95M 2026-03
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Laboratorios Farma EUR 105.28M 177.08M 2025-06
Medical Developments International AUD 7.35M 7.37M 2025-06
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Neuren Pharmaceuticals AUD 6.69M 6.37M 2025-06
Organigram Holdings CAD 16.41M 6.91M 2026-03
Pacira USD 133.91M 7.27M 2026-06
Perrigo USD 313.9M 11.6M 2026-06
Pharma Mar EUR 44.87M 5.63M 2026-06
Qiagen NV USD 340.39M 30.78M 2026-06
Sartorius EUR 433.1M 18.6M 2026-06
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
Supernus Pharmaceuticals USD 160.06M 30.7M 2026-06
Tilray USD 57.47M 10.16M 2025-06
Zealand Pharma A/S 34M 34.92M 2026-03
Zz Pientze Pharmaceu CNY 1.16B 860.2M 2026-03